Jilin Aodong Pharmaceutical Group Co.,Ltd.’s Net Profit Dropped 47.4% in First Three Quarters of 2022

Jilin Aodong Pharmaceutical Group Co.,Ltd. (吉林敖东药业集团股份有限公司) (000623.SZ) reported a net profit of 887.1 million yuan in the first three quarters of 2022, down 47.4% year-on-year.

Meanwhile, the company posted 1.9 billion yuan in revenue, up 19.7% year-on-year.

At the end of the reporting period, it had 29.9 billion yuan in total assets and 4.3 billion yuan in total liabilities, with a liability-to-asset ratio of 14.5%.